v2.4.1.9

Segment reporting (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2015
Segment Reporting [Abstract] |
Summary of Segment Net Revenues, Segment Operating Income Loss and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes | The following is a summary of segment net revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:
|  | Three months ended |
|  | March 31, |
|  | 2015 |  |  | 2014 |
Segment net revenues: |  |  |  |  |  |  |  |
U.S. dialysis and related lab services |  |  |  |  |  |  |  |
Patient service revenues: |  |  |  |  |  |  |  |
External sources |  | $ | 2,154,294 |  |  | $ | 2,028,743 |
Intersegment revenues |  |  | 11,856 |  |  |  | 7,832 |
Total dialysis and related lab services revenues |  |  | 2,166,150 |  |  |  | 2,036,575 |
Less: Provision for uncollectible accounts |  |  | (97,477 | ) |  |  | (81,463 | )
Net dialysis and related lab services patient service revenues |  |  | 2,068,673 |  |  |  | 1,955,112 |
Other revenues(1) |  |  | 3,184 |  |  |  | 3,154 |
Total net dialysis and related lab services revenues |  |  | 2,071,857 |  |  |  | 1,958,266 |
HCP |  |  |  |  |  |  |  |
HCP revenues: |  |  |  |  |  |  |  |
Capitated revenues |  |  | 832,472 |  |  |  | 771,542 |
Net patient service revenues |  |  | 80,210 |  |  |  | 56,222 |
Other revenues(2) |  |  | 15,053 |  |  |  | 12,523 |
Intersegment capitated and other revenues |  |  | 37 |  |  |  | 152 |
Total revenues |  |  | 927,772 |  |  |  | 840,439 |
Other—Ancillary services and strategic initiatives |  |  |  |  |  |  |  |
Net patient service revenues |  |  | 35,624 |  |  |  | 27,399 |
Capitated revenues |  |  | 18,043 |  |  |  | 16,023 |
Other external sources |  |  | 246,562 |  |  |  | 208,633 |
Intersegment revenues |  |  | 4,942 |  |  |  | 4,819 |
Total ancillary services and strategic initiatives revenues |  |  | 305,171 |  |  |  | 256,874 |
Total net segment revenues |  |  | 3,304,800 |  |  |  | 3,055,579 |
Elimination of intersegment revenues |  |  | (16,835 | ) |  |  | (12,803 | )
Consolidated net revenues |  | $ | 3,287,965 |  |  | $ | 3,042,776 |
Segment operating margin (loss): |  |  |  |  |  |  |  |
U.S. dialysis and related lab services |  | $ | (104,489 | ) |  | $ | 386,700 |
HCP |  |  | 60,294 |  |  |  | 53,953 |
Other—Ancillary services and strategic initiatives |  |  | (13,828 | ) |  |  | 1,678 |
Total segment margin (loss) |  |  | (58,023 | ) |  |  | 442,331 |
Reconciliation of segment operating margin to consolidated income from continuing operations before income taxes: |  |  |  |  |  |  |  |
Corporate support costs |  |  | (6,133 | ) |  |  | (1,106 | )
Consolidated operating (loss) income |  |  | (64,156 | ) |  |  | 441,225 |
Debt expense |  |  | (97,392 | ) |  |  | (106,335 | )
Other (loss) income |  |  | (533 | ) |  |  | 1,698 |
Consolidated (loss) income from continuing operations before income taxes |  | $ | (162,081 | ) |  | $ | 336,588 |
(1) | Includes management fees for providing management and administrative services to dialysis centers that are wholly-owned by third parties or centers in which the Company owns a minority equity investment.
(2) | Includes payments received for medical consulting services and management fees for providing management and administrative services to an unconsolidated joint venture that provides medical services in which the Company owns a 50% interest, as well as revenue related to the maintenance of existing physician networks.
Summary of Depreciation and Amortization Expense by Segment | Depreciation and amortization expense by segment is as follows:
|  | Three months ended |
|  | March 31, |
|  | 2015 |  |  | 2014 |
U.S. dialysis and related lab services. |  | $ | 104,993 |  |  | $ | 96,443 |
HCP |  |  | 43,279 |  |  |  | 41,737 |
Ancillary services and strategic initiatives |  |  | 5,517 |  |  |  | 4,399 |
|  | $ | 153,789 |  |  | $ | 142,579 |
Summary of Assets by Segment | Summary of assets by segment is as follows:
|  | March 31, |  |  | December 31, |
|  | 2015 |  |  | 2014 |
Segment assets |  |  |  |  |  |  |  |
U.S. dialysis and related lab services (including equity investments of $28,406 and $28,138, respectively) |  | $ | 11,352,546 |  |  | $ | 10,959,096 |
HCP (including equity investments of $19,709 and $15,393, respectively) |  |  | 6,313,981 |  |  |  | 6,285,984 |
Other—Ancillary services and strategic initiatives (including equity investments of $21,902 and $22,106, respectively) |  |  | 700,136 |  |  |  | 697,635 |
Consolidated assets |  | $ | 18,366,663 |  |  | $ | 17,942,715 |
Summary of Expenditures for Property and Equipment by Segment | Expenditures for property and equipment by segment is as follows:
|  | Three months ended |
|  | March 31, |
|  | 2015 |  |  | 2014 |
U.S. dialysis and related lab services. |  | $ | 105,395 |  |  | $ | 113,230 |
HCP |  |  | 5,034 |  |  |  | 4,502 |
Ancillary services and strategic initiatives |  |  | 10,992 |  |  |  | 8,830 |
|  | $ | 121,421 |  |  | $ | 126,562 |

X
- Definition Reconciliation of capital expenditures for property and equipment from segment to consolidated. + References No definition available. + Details
Name: | dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock
Namespace Prefix: | dva_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, and discontinued operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration